What triggers Calcium Pyrophosphate Deposition Disease (CPPD), also known as pseudogout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pseudogout is typically triggered by several factors, including aging, joint trauma, metabolic conditions like hyperparathyroidism, hemochromatosis, hypomagnesemia, and hypophosphatasia, dehydration, certain medications, and rapid changes in calcium levels. These triggers increase the risk of calcium pyrophosphate crystal formation in joints, leading to pseudogout attacks. According to the study by 1, optimal treatment of CPPD requires both non-pharmacological and pharmacological modalities and should be tailored according to clinical features, general risk factors, and the presence of a predisposing metabolic disorder. Some key triggers to consider include:

  • Aging, as pseudogout prevalence increases with age due to cartilage degeneration
  • Joint trauma or surgery, which can disrupt cartilage and release crystals into the joint space
  • Metabolic conditions like hyperparathyroidism, hemochromatosis, hypomagnesemia, and hypophosphatasia, which increase risk by altering calcium metabolism
  • Dehydration, which concentrates joint fluid, potentially precipitating crystal formation
  • Certain medications, particularly diuretics that affect electrolyte balance, may trigger attacks
  • Rapid changes in calcium levels, such as after parathyroid surgery, can also precipitate pseudogout
  • Genetic factors, with family history increasing susceptibility It's essential to recognize these triggers to manage this painful condition effectively, primarily affecting larger joints like knees, wrists, and ankles. Additionally, a study by 1 highlights the importance of maintaining proper hydration and treating underlying metabolic conditions, such as hypomagnesemia, to prevent pseudogout attacks.

From the Research

Pseudogout Triggers

  • Pseudogout, also known as calcium pyrophosphate dihydrate (CPPD) crystal-related arthropathies, can be triggered by various factors, including:
    • Hyperparathyroidism, as pseudogout has been suggested to be a diagnostic clue of hyperparathyroidism or a complication after parathyroidectomy that abruptly relieves hypercalcemia 2
    • Relative hypocalcemia after parathyroidectomy, which can stimulate crystal shedding into synovial fluid and precipitate acute attacks of pseudogout 2
    • Chondrocalcinosis, which is the deposition of calcium pyrophosphate dihydrate crystals in articular cartilage, and is often associated with pseudogout 3, 2
  • There is no standard regimen for long-term chronic therapies of pseudogout, and current treatment approaches are mainly directed at relieving the symptoms of joint inflammation 4, 3
  • The pathogenesis of crystal-induced joint inflammation and subsequent joint degeneration is complex, and involves the activation of the innate immune system, including the NACHT, LRR and PYD domains-containing protein 3 (NALP-3) inflammasome 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment and management of pseudogout: insights for the clinician.

Therapeutic advances in musculoskeletal disease, 2012

Related Questions

What are the treatments for Calcium Pyrophosphate Deposition Disease (CPPD), also known as pseudogout?
Is calcium pyrophosphate deposition disease (CPPD) recurring?
What is the most important point to know about Pseudogout, also known as Calcium Pyrophosphate Deposition Disease (CPPD), in a medical context?
What are the causes of pseudogout?
What is the difference between gout and pseudogout?
What factors influence primary care physician referral patterns, including word of mouth, prior experience with healthcare provider?
What bile acid level is diagnostic for intrahepatic cholestasis of pregnancy (ICP)?
What is the medical term for normal nodularity, such as in fibroadenoma, during a breast examination?
What is the optimal management for a 48-year-old female with hypertension (HTN), presenting with chronically elevated systolic blood pressure, currently treated with losartan (Angiotensin II Receptor Antagonist) 100mg daily, doxazosin (Alpha-1 Adrenergic Receptor Antagonist) 2mg daily, amlodipine (Calcium Channel Blocker) 10mg daily, metoprolol succinate (Beta-1 Selective Adrenergic Receptor Blocker) 25mg daily, and spironolactone (Mineralocorticoid Receptor Antagonist)/hydrochlorothiazide (HCTZ) (Thiazide Diuretic) 25-25mg daily?
What is the cause of a 45-year-old female's vaginal odor resembling tuna fish after using potentially contaminated sex toys, specifically those that may not have been properly cleaned?
What are the recommendations for Pneumococcal Conjugate Vaccine (PCV) 20 after receiving Pneumococcal Polysaccharide Vaccine (PPSV) 23 and PCV 13 on the same day?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.